Literature DB >> 20161095

Induced pluripotent reprogramming from promiscuous human stemness related factors.

Timothy J Nelson1, Almudena Martinez-Fernandez, Satsuki Yamada, Amber A Mael, Andre Terzic, Yasuhiro Ikeda.   

Abstract

Ectopic expression of pluripotency gene sets provokes nuclear reprogramming in permissive somatic tissue environments generating induced pluripotent stem (iPS) cells. The evolutionary conserved function of stemness orthologs was here tested through interspecies transduction. A spectrum of HIV-based lentiviral vectors was designed, and point mutations in the HIV-1 capsid region identified for efficient infectivity and expanded trans-species tropism. Human pluripotent gene sequences, OCT3/4, SOX2, KLF4 and c-MYC, packaged into engineered lentiviral expression vectors achieved consistent expression in non-human fibroblasts. Despite variation in primary amino-acid sequence between species, introduction of human pluripotent genes produced cell lines with embryonic stem cell-like morphology. Transduced fibroblasts differentiated in vitro into all three germ layers according to gastrulation gene expression profiles, and formed in vivo teratoma with multi-lineage potential. Reprogrammed progeny incorporated into non-human morula to produce blastomeres capable of developing into chimeric embryos with competent organogenesis. This model system establishes a prototypic approach to examine consequences of human stemness factors induced reprogramming in the context of normal embryonic development, exploiting non-human early stage embryos. Thus, ectopic xeno-transduction across species unmasks the promiscuous nature of stemness induction, suggesting evolutionary selection of core processes for somatic tissue reprogramming.

Entities:  

Keywords:  HIV; KLF4; OCT3/4; SOX2; c-MYC; chimera; iPS; lentiviral; ortholog

Mesh:

Substances:

Year:  2009        PMID: 20161095      PMCID: PMC2745150          DOI: 10.1111/j.1752-8062.2009.00091.x

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


  54 in total

1.  Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts.

Authors:  Haisong Liu; Fangfang Zhu; Jun Yong; Pengbo Zhang; Pingping Hou; Honggang Li; Wei Jiang; Jun Cai; Meng Liu; Kai Cui; Xiuxia Qu; Tingting Xiang; Danyu Lu; Xiaochun Chi; Ge Gao; Weizhi Ji; Mingxiao Ding; Hongkui Deng
Journal:  Cell Stem Cell       Date:  2008-12-04       Impact factor: 24.633

Review 2.  Interspecies nuclear transfer: implications for embryonic stem cell biology.

Authors:  Zeki Beyhan; Amy E Iager; Jose B Cibelli
Journal:  Cell Stem Cell       Date:  2007-11       Impact factor: 24.633

3.  Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts.

Authors:  Prashant Mali; Zhaohui Ye; Holly H Hommond; Xiaobing Yu; Jeff Lin; Guibin Chen; Jizhong Zou; Linzhao Cheng
Journal:  Stem Cells       Date:  2008-05-29       Impact factor: 6.277

4.  Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo.

Authors:  R Zufferey; D Nagy; R J Mandel; L Naldini; D Trono
Journal:  Nat Biotechnol       Date:  1997-09       Impact factor: 54.908

5.  Species-specific, postentry barriers to primate immunodeficiency virus infection.

Authors:  W Hofmann; D Schubert; J LaBonte; L Munson; S Gibson; J Scammell; P Ferrigno; J Sodroski
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter.

Authors:  Christophe Demaison; Kathryn Parsley; Gaby Brouns; Michaela Scherr; Karin Battmer; Christine Kinnon; Manuel Grez; Adrian J Thrasher
Journal:  Hum Gene Ther       Date:  2002-05-01       Impact factor: 5.695

7.  Embryonic stem cell therapy of heart failure in genetic cardiomyopathy.

Authors:  Satsuki Yamada; Timothy J Nelson; Ruben J Crespo-Diaz; Carmen Perez-Terzic; Xiao-Ke Liu; Takashi Miki; Susumu Seino; Atta Behfar; Andre Terzic
Journal:  Stem Cells       Date:  2008-07-31       Impact factor: 6.277

8.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

9.  KCNJ11 knockout morula re-engineered by stem cell diploid aggregation.

Authors:  Timothy J Nelson; Almudena Martinez-Fernandez; Andre Terzic
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-01-27       Impact factor: 6.237

10.  Genomic chart guiding embryonic stem cell cardiopoiesis.

Authors:  Randolph S Faustino; Atta Behfar; Carmen Perez-Terzic; Andre Terzic
Journal:  Genome Biol       Date:  2008-01-09       Impact factor: 13.583

View more
  26 in total

1.  Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells.

Authors:  Timothy J Nelson; Almudena Martinez-Fernandez; Satsuki Yamada; Carmen Perez-Terzic; Yasuhiro Ikeda; Andre Terzic
Journal:  Circulation       Date:  2009-07-20       Impact factor: 29.690

2.  c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.

Authors:  Almudena Martinez-Fernandez; Timothy J Nelson; Yasuhiro Ikeda; Andre Terzic
Journal:  J Cardiovasc Transl Res       Date:  2010-02       Impact factor: 4.132

Review 3.  Targeted gene therapy for the treatment of heart failure.

Authors:  Kleopatra Rapti; Antoine H Chaanine; Roger J Hajjar
Journal:  Can J Cardiol       Date:  2011 May-Jun       Impact factor: 5.223

Review 4.  Energy metabolism in nuclear reprogramming.

Authors:  Clifford D L Folmes; Timothy J Nelson; Andre Terzic
Journal:  Biomark Med       Date:  2011-12       Impact factor: 2.851

5.  A comparison of pluripotency and differentiation status of four mesenchymal adult stem cells.

Authors:  Fatemeh Jamshidi Adegani; Lida Langroudi; Ehsan Arefian; Abbas Shafiee; Peyman Dinarvand; Masoud Soleimani
Journal:  Mol Biol Rep       Date:  2012-12-29       Impact factor: 2.316

6.  Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming.

Authors:  Clifford D L Folmes; Timothy J Nelson; Almudena Martinez-Fernandez; D Kent Arrell; Jelena Zlatkovic Lindor; Petras P Dzeja; Yasuhiro Ikeda; Carmen Perez-Terzic; Andre Terzic
Journal:  Cell Metab       Date:  2011-08-03       Impact factor: 27.287

7.  Noninvasive 3-dimensional imaging of liver regeneration in a mouse model of hereditary tyrosinemia type 1 using the sodium iodide symporter gene.

Authors:  Raymond D Hickey; Shennen A Mao; Bruce Amiot; Lukkana Suksanpaisan; Amber Miller; Rebecca Nace; Jaime Glorioso; Michael K O'Connor; Kah Whye Peng; Yasuhiro Ikeda; Stephen J Russell; Scott L Nyberg
Journal:  Liver Transpl       Date:  2015-03-12       Impact factor: 5.799

8.  Selection via pluripotency-related transcriptional screen minimizes the influence of somatic origin on iPSC differentiation propensity.

Authors:  Katherine A Hartjes; Xing Li; Almudena Martinez-Fernandez; Alexa J Roemmich; Brandon T Larsen; Andre Terzic; Timothy J Nelson
Journal:  Stem Cells       Date:  2014-09       Impact factor: 6.277

9.  Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells.

Authors:  Clifford D L Folmes; Almudena Martinez-Fernandez; Randolph S Faustino; Satsuki Yamada; Carmen Perez-Terzic; Timothy J Nelson; Andre Terzic
Journal:  J Cardiovasc Transl Res       Date:  2012-12-18       Impact factor: 4.132

10.  iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism.

Authors:  Almudena Martinez-Fernandez; Timothy J Nelson; Satsuki Yamada; Santiago Reyes; Alexey E Alekseev; Carmen Perez-Terzic; Yasuhiro Ikeda; Andre Terzic
Journal:  Circ Res       Date:  2009-08-20       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.